Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives $573.42 Average Target Price from Analysts

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been given a consensus recommendation of “Moderate Buy” by the twenty-eight ratings firms that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation, nineteen have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $569.20.

A number of research firms recently commented on ISRG. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. BMO Capital Markets assumed coverage on shares of Intuitive Surgical in a research report on Wednesday. They set an “outperform” rating and a $518.00 target price for the company. HSBC lowered their price target on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Jefferies Financial Group dropped their price target on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a research report on Wednesday, April 22nd. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of Intuitive Surgical stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the completion of the transaction, the director directly owned 120 shares of the company’s stock, valued at approximately $55,620. This trade represents a 49.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 7,169 shares of company stock valued at $3,059,135. 0.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds have recently added to or reduced their stakes in ISRG. Newbridge Financial Services Group Inc. increased its stake in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 33 shares in the last quarter. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at $25,000. Olistico Wealth LLC bought a new position in Intuitive Surgical during the fourth quarter worth $28,000. Laurel Wealth Advisors LLC bought a new position in Intuitive Surgical during the fourth quarter worth $31,000. Finally, Turning Point Benefit Group Inc. grew its holdings in Intuitive Surgical by 833.3% in the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 50 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

NASDAQ ISRG traded down $4.77 on Monday, reaching $406.78. The company had a trading volume of 1,858,933 shares, compared to its average volume of 2,319,796. The firm has a market cap of $144.07 billion, a price-to-earnings ratio of 49.31, a P/E/G ratio of 3.35 and a beta of 1.46. Intuitive Surgical has a fifty-two week low of $396.68 and a fifty-two week high of $603.88. The business has a 50 day moving average of $422.09 and a two-hundred day moving average of $474.65.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same period in the previous year, the business earned $1.81 EPS. The business’s quarterly revenue was up 23.0% compared to the same quarter last year. As a group, research analysts predict that Intuitive Surgical will post 8.57 earnings per share for the current fiscal year.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: BMO Capital Markets upgraded Intuitive Surgical to strong-buy, which can help sentiment by signaling confidence in the stock’s long-term outlook. Zacks.com
• Positive Sentiment: Investor interest remains supported by expectations that July 16 results will show higher sales and EPS, with strong adoption of the da Vinci 5 surgical robot seen as a key growth driver. ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?
• Neutral Sentiment: Evercore ISI cut its price target to $430 from $480 while keeping an In Line rating, suggesting the company still has growth potential but investors may be more cautious on near-term upside. Is Intuitive Surgical (ISRG) One Of MedTech’s Best AI Stock To Buy?
• Neutral Sentiment: Options traders are pricing in a wide range of outcomes for ISRG ahead of earnings, reflecting uncertainty around how the report and guidance could move the stock. Just How Much Risk Is Built Into ISRG Stock?
• Negative Sentiment: Investors are weighing possible margin pressure, which could limit enthusiasm even if revenue and earnings grow next quarter. ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.